This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignees: Sunnybrook Research Institute, Vasomune Therapeutics Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2022
Title: Jason Moss - Innovator in Angiogenesis
Introduction
Jason Moss, an accomplished inventor based in Petaluma, CA, has made significant contributions to the field of biomedical innovations. With one patent to his name, he has focused on developing novel agents that promote angiogenesis, a crucial process for wound healing and tissue regeneration.
Latest Patents
His notable patent, titled "Agent for promoting angiogenesis and methods and uses thereof," encompasses compounds that are multimeric forms of a monomeric binding peptide bonded to PEG moieties. These innovative multimers have been shown to effectively stimulate angiogenesis and enhance wound healing. Additionally, the patent details pharmaceutical compositions that include these multimers, suitable for either topical or systemic administration.
Career Highlights
Throughout his career, Jason has been associated with prominent organizations, including Vasomune Therapeutics Inc. and Sunnybrook Research Institute. His work has involved extensive research aimed at refining new therapies aimed at improving healing outcomes in various medical applications.
Collaborations
Collaborating with notable professionals in the field, Jason has worked alongside colleagues such as Daniel J. Dumont and Paul Van Slyke. These partnerships have helped foster innovation and propel advancements in the scientific community.
Conclusion
With his commitment to advancing healthcare through innovative inventions, Jason Moss exemplifies the dynamic spirit of inventorship. His contributions to angiogenesis research are paving the way for new treatments that enhance the healing process, demonstrating the vital role of inventors in the ongoing quest for medical breakthroughs.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile